NCS Multistage (NCSM) Emerging Growth Virtual Conference summary
Event summary combining transcript, slides, and related documents.
Emerging Growth Virtual Conference summary
27 Dec, 2025Company overview and market positioning
Focuses on technology-driven oilfield services and equipment for E&P customers, competing with larger firms by targeting niche leadership positions and attractive margins.
Operates a capital-light business model by outsourcing manufacturing, enabling low capex (1%-2% of revenue) and strong free cash flow.
Revenue in 2024 was over $160 million, with EBITDA of $22 million and free cash flow of $12 million; no customer exceeds 10% of revenue.
Trades on NASDAQ with a market cap and enterprise value just below $100 million.
Over 200 customers in 2024, with limited shareholder concentration.
Product lines and innovation
Four main product lines: fracturing systems (65% of revenue), Repeat Precision, Tracer Diagnostics, and well construction.
Fracturing systems are consumable, used in 30% of Canadian wells, and expanding internationally; recent wells use up to 290 sleeves per well.
Repeat Precision offers high-performance composite and dissolvable frac plugs, with new features for simul-frac operations and growing Canadian market share.
Tracer Diagnostics provides cost-effective tracer studies for well optimization, with labs in Tulsa and Calgary, supporting operational decisions and field development.
Well construction features the AirLock Casing Buoyancy System, supporting longer laterals and capital efficiency.
Strategic direction and growth
Strategy centers on building market leadership, expanding internationally (especially offshore), and commercializing innovative solutions.
International revenue more than doubled in 2024, now over 10% of total revenue, driven by North Sea and Middle East growth.
Revenue grew 14% in 2024 ($20 million increase), with expectations for further growth in 2025 despite a flat North American market.
Gross margin improved by 250 basis points in 2024, aided by international mix; SG&A remains controlled and relatively fixed.
Adjusted EBITDA margin incrementally reached 35% from 2020 to 2024, with long-term incremental margins targeted at 25%-35%.
Latest events from NCS Multistage
- 2025 delivered double-digit revenue and EBITDA growth, with 2026 guidance projecting further gains.NCSM
Q4 20256 Mar 2026 - Q2 2024 revenue up 17% with improved margins and raised 2024 guidance on strong international growth.NCSM
Q2 20242 Feb 2026 - Q3 2024 revenue up 15% year-over-year, with strong global demand and margin expansion.NCSM
Q3 202417 Jan 2026 - Record international growth, margin expansion, and strong cash position highlight 2024 results.NCSM
Q4 202425 Dec 2025 - Q1 revenue and profit surged on Canadian and international strength, with margins expanding.NCSM
Q1 202524 Dec 2025 - Up to $200M in common stock registered for sale, supporting growth amid oilfield sector risks.NCSM
Registration Filing16 Dec 2025 - Strong international growth, margin expansion, and strategic acquisitions drive robust free cash flow.NCSM
Sidoti's Year End Virtual Investor Conference12 Dec 2025 - Stockholders will vote on directors, auditor, executive pay, and an expanded equity plan.NCSM
Proxy Filing1 Dec 2025 - Key votes include director elections, auditor ratification, and executive pay approval.NCSM
Proxy Filing1 Dec 2025